1
/
of
0
FDA Drug Approval, N209354, DUOBRII
FDA Drug Approval, N209354, DUOBRII
Regular price
$89.00 USD
Regular price
Sale price
$89.00 USD
Unit price
/
per
NDA: 209354
Company: BAUSCH
Drug Name: DUOBRII
Active Ingredients: HALOBETASOL PROPIONATE; TAZAROTENE
Strength: 0.01%;0.045%
Dosage Form/Route: LOTION;TOPICAL
Action Date: 04/25/2019
Marketing Status: Prescription
Submission Classification: Type 4 - New Combination
Company: BAUSCH
Drug Name: DUOBRII
Active Ingredients: HALOBETASOL PROPIONATE; TAZAROTENE
Strength: 0.01%;0.045%
Dosage Form/Route: LOTION;TOPICAL
Action Date: 04/25/2019
Marketing Status: Prescription
Submission Classification: Type 4 - New Combination
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details